Cipla USA, Inc. recalls
12 notices naming Cipla USA, Inc. as the recalling firm, since November 20, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Cipla USA, Inc.: Fosfomycin Tromethamine Granules for Oral Solution
Hazard (FDA): Failed Impurities/Degradation Specifications
FDAMedicines
Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets and 2 more
Hazard (FDA): cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
FDAMedicines
Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets and 2 more
Hazard (FDA): CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
FDAMedicines
Sterility
Cipla USA, Inc.: Lanreotide Injection and 1 more
Hazard (FDA): Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
FDAMedicines
Cipla USA, Inc.: Nilotinib Capsules and 1 more
Hazard (FDA): Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
FDAMedicines
Cipla USA, Inc.: Cinacalcet Hydrochloride Tablets and 2 more
Hazard (FDA): CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
FDAMedicines
Cipla USA, Inc.: Lanthanum Carbonate chewable tablets and 1 more
Hazard (FDA): Failed stability specifications: Out of specification for hardness test
FDAMedicines
Cipla USA, Inc.: Albuterol Sulfate
Hazard (FDA): Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.
FDAMedicines
Sterility
Cipla USA, Inc.: Budesonide Inhalation Suspension
Hazard (FDA): Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
FDAMedicines
Cipla USA, Inc.: Lanthanum Carbonate Chewable Tablets and 1 more
Hazard (FDA): Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
FDAMedicines